Comparative guide · 7 min read

Schisandra vs ashwagandha for stress

Updated 2026-05-20 · Reviewed by SupplementScore editors · No sponsorships

Both are classical adaptogens — schisandra (Schisandra chinensis, "five-flavour berry") from Chinese and Russian traditional use, ashwagandha (Withania somnifera) from Ayurveda. Both have modern clinical trials, but the trial depth differs sharply. Ashwagandha now has more than a dozen RCTs on cortisol, perceived stress, and sleep. Schisandra's modern human trial base is smaller and more concentrated in fatigue and liver-protection endpoints than stress per se. Both are Tier 2 in our database, but the depth of evidence for stress sits with ashwagandha.

Quick verdict

GoalBetter choiceWhy
Perceived stress and salivary cortisolAshwagandhaMultiple RCTs (Chandrasekhar 2012, Lopresti 2019, Salve 2019) show 18–28% reduction in perceived stress scores and meaningful cortisol reductions at 300–600 mg KSM-66 or Shoden extract.
Mental fatigue / attention under loadSchisandraThe Russian sport-cosmonaut literature and Panossian-era trials show modest improvement in attention and mental performance under fatigue. Ashwagandha has less data here.
Sleep quality with stress componentAshwagandhaLangade 2019 and Salve 2020 trials show improved sleep-onset and quality at 300 mg/day. Schisandra has no comparable sleep trial.
Liver-supporting / hepatoprotectiveSchisandraSchisandrins have a modest but reproducible signal on ALT and AST in fatty-liver and hepatitis adjunct studies. Ashwagandha has no notable liver trial record.
Daytime calmness without sedationSchisandra (slightly)Schisandra has a mildly alerting profile; ashwagandha is more sedating in some users — useful at night, less ideal as a morning supplement.
Cost per effective doseAshwagandhaGeneric ashwagandha root extract runs $10–18/month; KSM-66 or Sensoril branded runs $20–35/month. Schisandra extracts run $15–25/month at standardised dosing.

How they compare on the things that matter

Mechanism — what they actually do

Ashwagandha's withanolides (especially withaferin A and the withanolides A–H) modulate HPA-axis signalling at multiple points — including cortisol receptor responsiveness in animal models and GABAergic activity in vitro. The clinical phenotype is dose-dependent: lower doses (~300 mg) are more "calming with sleep benefit"; higher doses (600 mg+) may be more sedating.

Schisandra's schisandrins (B, C, A) act on the Nrf2 pathway and CYP450 enzymes in vitro and animal work, with possible HPA-axis modulation but smaller cortisol signal in human trials. The traditional indication is "five-flavour" tonic for fatigue and recovery, particularly mental fatigue under workload.

Evidence base

Safety and side-effects

Ashwagandha is well tolerated in most users; GI upset and mild sedation are the most common complaints. Hepatotoxicity case reports have accumulated over the past 5 years — rare but real, particularly with high-withanolide branded extracts in the 500–1000 mg/day range and prolonged use. The 2024 LiverTox update added ashwagandha to the watch list. Avoid in pregnancy (theoretical abortifacient signal), and use cautiously with autoimmune-thyroid disease (ashwagandha modestly raises T4 in some patients). Discontinue and seek medical review if any signs of liver injury (jaundice, dark urine, RUQ pain) emerge.

Schisandra is well tolerated short term; GI upset (5–10%) is the most common complaint. Acid reflux can worsen owing to the natural acidity of the berry. CYP3A4 induction at high doses can theoretically alter the metabolism of CYP3A4-cleared drugs — relevant in transplant patients on tacrolimus or cyclosporine. Pregnancy use is not well established — avoid.

Practical rule. For the "I feel stressed and don't sleep well" pattern in an otherwise-healthy adult, ashwagandha has the deeper trial base and the cleaner stress-cortisol-sleep effect. For "mental fatigue under workload, with fatty-liver or recovery emphasis", schisandra is the more apt pick. The recent hepatotoxicity signals around ashwagandha mean it should not be assumed risk-free in long-term high-dose use.

What the price difference buys you

Generic ashwagandha root extract is cheap and widely available, but content varies. KSM-66 and Sensoril are the two extract brands with the largest trial backing — pay for one of those rather than a generic. Schisandra extracts standardised to total schisandrins (lignans) are less brand-fragmented; look for a product specifying at least 2% total schisandrins at the trial-dose range of 500 mg–1.5 g/day.

Who should skip each

Ashwagandha should be avoided in pregnancy, in active autoimmune-thyroid disease (until stable on treatment), and in patients with active or recent liver injury or significant alcohol use. Pause 1–2 weeks before any planned surgery. Monitor for signs of hepatic injury during chronic use and discontinue immediately if they appear.

Schisandra should be avoided in pregnancy, with caution in patients with GERD or peptic ulcer disease, and in patients on tacrolimus, cyclosporine, or other narrow-therapeutic-window CYP3A4 substrates.

What we'd actually buy

For acute and chronic stress with sleep impairment: KSM-66 ashwagandha 300 mg twice daily for 8–12 weeks. Reassess and consider a 1–2 week break before continuing. Discontinue if any signs of liver injury appear. Pair with the rest of an evidence-based stress strategy (sleep, exercise, therapy where indicated).

For mental fatigue under workload, or as a hepatic-supportive adjunct in metabolic-associated fatty liver disease alongside a real treatment plan: standardised schisandra 500 mg–1 g/day in the morning or split twice daily, for 8 weeks. Take with food to reduce reflux risk.

Sources

Read more: